Skip to main content
Signal8

O'Connor Daniel J.

SEC insider (Form 3/4/5 filer). CIK 0001376847. Director at DiaMedica Therapeutics Inc. (DMAC). 2 reported Form 4/5 transactions since Sep 2024; latest on Jun 1, 2026. Located in MINNEAPOLIS, MN.

Companies O'Connor Daniel J. has filed insider reports for

  • DiaMedica Therapeutics Inc. (DMAC): Director
O'Connor Daniel J. profile photo

O'Connor Daniel J.

CIK: 0001376847

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

DiaMedica Therapeutics Inc. logo
DMAC

DiaMedica Therapeutics Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • DiaMedica Therapeutics Inc. logo
    DMAC

    DiaMedica Therapeutics Inc.

    Jun 1, 2026
    Award

    Stock Option (right to buy)

    Direct
    40.4K shares-
  • DiaMedica Therapeutics Inc. logo
    DMAC

    DiaMedica Therapeutics Inc.

    Feb 20, 2025
    Award

    Stock Option (right to buy)

    Direct
    64.2K shares-

1-2 of 2